Capricor Therapeutics Inc (CAPR)

Apr 21, 2026

Roth Capital Maintains Capricor Therapeutics (CAPR) Buy Recommendation - MSN

Apr 21, 2026

Apr 17, 2026

Top 10 healthcare stocks by forward P/E: From Capricor's 418x to Alignment Healthcare's 48x - MSN

Apr 17, 2026

Apr 17, 2026

CAPR Stock Gains Steam: Former Capricor Exec Could Become FDA’s Top Gene Therapy Regulator Ahead Of High-Stakes DMD Decision - Stocktwits

Apr 17, 2026

Apr 17, 2026

CAPR Should I Buy - Intellectia AI

Apr 17, 2026

Apr 16, 2026

Capricor Therapeutics (CAPR) Leads Healthcare Stocks with High F - GuruFocus

Apr 16, 2026

Apr 16, 2026

Capricor Therapeutics stock jumps as FDA resumes Deramiocel review - MSN

Apr 16, 2026

Apr 15, 2026

Short Interest in Capricor Therapeutics, Inc. (NASDAQ:CAPR) Increases By 34.6% - MarketBeat

Apr 15, 2026

Apr 15, 2026

The Technical Signals Behind (CAPR) That Institutions Follow - Stock Traders Daily

Apr 15, 2026

Apr 15, 2026

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Apr 15, 2026

Apr 14, 2026

Roth MKM Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $43 - Moomoo

Apr 14, 2026

Apr 14, 2026

Capricor's Former Executive Considered for FDA Biologics Chief - Intellectia AI

Apr 14, 2026

Apr 14, 2026

CAPR Stock Price, Quote & Chart | CAPRICOR THERAPEUTICS INC (NASDAQ:CAPR) - ChartMill

Apr 14, 2026

Apr 13, 2026

Capricor Therapeutics (NASDAQ:CAPR) Shares Up 9.7%Should You Buy? - MarketBeat

Apr 13, 2026

Apr 10, 2026

Q3 2025 Capricor Therapeutics Inc Earnings Call Transcript - GuruFocus

Apr 10, 2026

Apr 10, 2026

[ARS] CAPRICOR THERAPEUTICS, INC. SEC Filing - Stock Titan

Apr 10, 2026

Apr 10, 2026

Capricor Therapeutics | DEF 14A: Definitive information statements - Moomoo

Apr 10, 2026

Apr 10, 2026

Capricor Therapeutics (NASDAQ: CAPR) details 2026 meeting, board elections, pay and Deramiocel deals - Stock Titan

Apr 10, 2026

Apr 10, 2026

Capricor Therapeutics (CAPR) reports positive phase 3 HOPE-3 data and $318M 2025 cash balance - MSN

Apr 10, 2026

Apr 10, 2026

Aug Update: Is Capricor Therapeutics Inc stock a value trapMarket Performance Recap & Technical Analysis for Trade Confirmation - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Capricor Therapeutics, Inc.Common Stock (NQ: CAPR - The Chronicle-Journal

Apr 09, 2026

Apr 09, 2026

JPMorgan Chase Reduces Stake in Capricor Therapeutics - National Today

Apr 09, 2026

Apr 09, 2026

JPMorgan Chase & Co. Decreases Stock Position in Capricor Therapeutics, Inc. $CAPR - MarketBeat

Apr 09, 2026

Apr 09, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm

Apr 09, 2026

Apr 06, 2026

Aug PreEarnings: Whats the profit margin of Capricor Therapeutics IncQuarterly Profit Summary & Consistent Income Trade Ideas - baoquankhu1.vn

Apr 06, 2026

Apr 04, 2026

Precision Trading with Capricor Therapeutics Inc. (CAPR) Risk Zones - Stock Traders Daily

Apr 04, 2026

Apr 04, 2026

Capricor Therapeutics (CAPR) Is Up 7.2% After HOPE-3 Data And PDUFA Update Has The Bull Case Changed? - Sahm

Apr 04, 2026

Apr 04, 2026

Capricor Therapeutics (CAPR) Valuation After New Deramiocel Data And Upcoming PDUFA Milestone - Sahm

Apr 04, 2026

Apr 03, 2026

Insider Selling: Capricor Therapeutics (NASDAQ:CAPR) Director Sells 7,529 Shares of Stock - marketbeat.com

Apr 03, 2026

Apr 03, 2026

Capricor Therapeutics (CAPR) director sells 7,529 exercised shares - Stock Titan

Apr 03, 2026

Apr 02, 2026

Option exercise and 10b5-1 sales reported by CAPR (NASDAQ: CAPR) - Stock Titan

Apr 02, 2026

Apr 02, 2026

Capricor Therapeutics (NASDAQ:CAPR) Trading Up 6.6%Here's Why - MarketBeat

Apr 02, 2026

Apr 02, 2026

Karimah Es Sabar Sells 61,265 Shares of Capricor Therapeutics (NASDAQ:CAPR) Stock - marketbeat.com

Apr 02, 2026

Apr 02, 2026

Insider Selling: Capricor Therapeutics (NASDAQ:CAPR) Director Sells $1,667,397.05 in Stock - marketbeat.com

Apr 02, 2026

Apr 02, 2026

Insider Selling: Capricor Therapeutics (NASDAQ:CAPR) CFO Sells 25,000 Shares of Stock - MarketBeat

Apr 02, 2026

Apr 02, 2026

CAPR SEC FilingsCapricor Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 02, 2026

Apr 01, 2026

Capricor Therapeutics(CAPR.US) Director Sells US$3.52 Million in Common Stock - Moomoo

Apr 01, 2026

Apr 01, 2026

Capricor Therapeutics EVP Krasney sells $752k in shares By Investing.com - Investing.com Canada

Apr 01, 2026

Apr 01, 2026

Capricor Therapeutics director sells $3.5m in shares - Investing.com UK

Apr 01, 2026

Apr 01, 2026

Capricor Therapeutics director sells $3.5m in shares By Investing.com - Investing.com Australia

Apr 01, 2026

Apr 01, 2026

Capricor (NASDAQ: CAPR) EVP sells 25K shares after option exercises - Stock Titan

Apr 01, 2026

Apr 01, 2026

Director at Capricor (NASDAQ: CAPR) sells 115,000 shares via 10b5-1 plan - Stock Titan

Apr 01, 2026

Apr 01, 2026

CAPR Stock Slumps But Wall Street Reiterates Optimism For Deramiocel Approval - MSN

Apr 01, 2026

Mar 31, 2026

Capricor Therapeutics (NASDAQ: CAPR) proxy: Board nominees, pay and Nippon Shinyaku deals - Stock Titan

Mar 31, 2026

Mar 31, 2026

[144] CAPRICOR THERAPEUTICS, INC. SEC Filing - Stock Titan

Mar 31, 2026

Mar 31, 2026

Capricor Therapeutics Stock Rises Above 50-Day Average - National Today

Mar 31, 2026

Mar 31, 2026

Capricor Therapeutics (NASDAQ:CAPR) Stock Passes Above 50 Day Moving AverageWhat's Next? - MarketBeat

Mar 31, 2026

Mar 30, 2026

Insider Sell: Is Capricor Therapeutics Inc stock a good dividend stock2026 Price Momentum & Safe Capital Preservation Plans - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

Value Recap: Is Capricor Therapeutics Inc a defensive stock2026 Levels & Weekly High Potential Stock Alerts - baoquankhu1.vn

Mar 30, 2026